Search

Displaying results 4271 - 4280 of 8469 in total
  1. Drug

    GW-870086

    go.drugbank.com/drugs/DB12322
    Investigational

    GW870086X has been investigated for the treatment of ASTHMA.

  2. Drug

    Ipamorelin

    go.drugbank.com/drugs/DB12370
    Investigational

    Ipamorelin has been investigated for the treatment of Ileus.

  3. Drug

    SJ-733

    go.drugbank.com/drugs/DB12659
    Investigational

    SJ-733 has been used in trials studying Malaria.

  4. Drug

    Vestipitant

    go.drugbank.com/drugs/DB11949
    Investigational

    Vestipitant has been investigated for the treatment of Tinnitus.

  5. Drug

    Abivertinib

    go.drugbank.com/drugs/DB15327
    Investigational

    [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. … cytokines at once, it may provide more pronounced clinical benefits as compared to agents targeting single pathways (e.g. interleukin-6 inhibitors).

  6. Drug

    FRAX1036

    go.drugbank.com/drugs/DB31834
    Experimental

    FRAX1036 is a p21-activated kinase (PAK) inhibitor.

  7. Drug

    Imagabalin

    go.drugbank.com/drugs/DB12105
    Investigational

    Imagabalin has been investigated in Generalized Anxiety Disorder.

  8. Drug

    NasoVAX

    go.drugbank.com/drugs/DB15859
    Investigational

    Created by Altimmune, Inc., NasoVAX is currently being developed for seasonal and pandemic use as it can activate humoral and cellular immune responses. … As of June 2020, NasoVAX is being evaluated in a Phase 2 clinical trial for safety and effectivness in preventing worsening symptoms in hospitalized COVID-19 patients (NCT04442230).

  9. Drug

    Exametazime

    go.drugbank.com/drugs/DB11179
    Approved

    It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex.

  10. Drug

    XMT-1001

    go.drugbank.com/drugs/DB06069
    Investigational

    XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human tumor xenografts models